Sign in Sign up free

← back to news

MergerJATTJATT II Acquisition Corp.

Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - BioSpace

By BioSpace·Google News·2026-06-29 at 9:08am ET·confidence: med

Read full article ↗

rssspecial_purpose_acquisition

More on JATT

2026-06-29JATT II Acquisition to Merge With Talawar Tx; JATT to Become Subsidiary in SPAC Deal - TradingView
2026-05-29JATT II Acquisition Corp. 1Q 2026: Net income $(68,793), EPS $(0.05) — 10-Q Summary - TradingView
2026-04-20JATT II Acquisition Corp Raises $60M for AI-Driven Biotech Hunt - BriefGlance
2026-04-20JATT II Acquisition (NASDAQ: JATT) completes $60M SPAC IPO raise - Stock Titan
2026-04-17JATT II Acquisition Corp. (JATT) Prices $63.0M SPAC IPO
2026-04-16JATT II Acquisition prices $60M SPAC IPO on Nasdaq - Investing.com